カテゴリー： 世界, 医療/バイオ, Grand View Research

世界のオピオイド市場（2023-2030）：製品別（IR/短時間作用型オピオイド、ER/長時間作用型オピオイド）、用途別（疼痛緩和、麻酔）、投与経路別、流通チャネル別、地域別

【英語タイトル】Opioid Market Size, Share & Trends Analysis Report By Product (IR/ Short Acting Opioids, ER/Long-Acting Opioids), By Application (Pain Relief, Anesthesia), By Route Of Administration, By Distribution Channel, By Region, And Segment Forecasts, 2023 - 2030

Grand View Researchが出版した調査資料（GRV23NOV277）・商品コード：GRV23NOV277
・発行会社（調査会社）：Grand View Research
・発行日：2023年9月
・ページ数：120
・レポート言語：英語
・レポート形式：PDF
・納品方法：Eメール（受注後3営業日）
・調査対象地域：グローバル
・産業分野：医薬品
◆販売価格オプション（消費税別）
Single UserUSD5,950 ⇒換算￥904,400見積依頼/購入/質問フォーム
Multi User/Five UserUSD6,950 ⇒換算￥1,056,400見積依頼/購入/質問フォーム
Global/corporate LicenseUSD8,950 ⇒換算￥1,360,400見積依頼/購入/質問フォーム
※販売価格オプションの説明
※お支払金額：換算金額（日本円）＋消費税
※納期：即日〜2営業日（3日以上かかる場合は別途表記又はご連絡）
※お支払方法：納品日＋5日以内に請求書を発行・送付（請求書発行日より2ヶ月以内に銀行振込、振込先：三菱UFJ銀行/H&Iグローバルリサーチ株式会社、支払期限と方法は調整可能）
❖ レポートの概要 ❖

オピオイド市場の成長と動向
Grand View Research, Inc.の最新レポートによると、世界のオピオイド市場規模は2030年までに253億米ドルに達し、予測期間中の年平均成長率は1.4%を記録する見込みです。市場成長に貢献する可能性のある製品を導入するために、メーカーを支援する規制政策です。例えば、2021年6月に米国FDAは、Purdue Pharma L.P.が開発した塩酸ナルメフェン注射剤を承認しました。ナルメフェン注射剤は、オピオイドの過剰摂取を逆転させるように設計されたオピオイド拮抗薬です。この製品の承認は、成長を促進すると予想されています。

さらに、2021年6月には、硫酸モルヒネ錠剤と硫酸モルヒネ内服液が、他の治療選択肢が少ない小児および成人患者の重度の疼痛管理用としてFDAから承認されました。このように、新たなオピオイドの承認とその上市もまた、成長を促進すると予想されます。

手術による術後痛の管理にオピオイドが使用されるケースが増加していることも、市場成長の原動力になると予想されます。Canadian Centre on Substance Use and Addictionによると、2020年には全人口の約11.8%が症状管理のためにオピオイド鎮痛薬を使用しています。同地域では、手術後のオピオイド処方として、トラマドールやコデインが頻繁に調剤されています。

疼痛管理のためのオピオイドに代わる非中毒性製品の出現は、オピオイド市場の成長低下につながります。American Society of Anesthesiologists（米国麻酔科学会）によると、市販のステロイドやアスピリン、イブプロフェン、アセトアミノフェンなどの非ステロイド性抗炎症薬など、オピオイド以外の医薬品がいくつかあります。さらに、これらの薬に関連する幅広い入手可能性と低コストは、予測期間中にそのような製品の需要の増加に貢献しています。例えば、アスピリンは30錠入りで10米ドルです。

さらに、2022年2月、米国FDAは、急性および慢性疼痛管理のためのHHS過剰摂取防止戦略の下、オピオイドに代わる非中毒性鎮痛薬の開発を奨励するイニシアチブを実施しました。FDAは製薬会社に対し、非オピオイド鎮痛薬の開発を推奨しています。こうした取り組みは、オピオイド市場全体の成長を抑制する可能性があります。

オピオイド市場レポートハイライト

- 製品別では、新規ER/長時間作用型オピオイドの承認・上市の増加により、ER/長時間作用型オピオイド分野が2022年に最大の市場シェアを獲得しました。例えば、2021年6月、米国FDAは疼痛管理を目的としたブプレノルフィン（Brixadi）の新薬承認申請を受理しました。ブプレノルフィンは徐放性長時間作用型オピオイド薬です。

- 用途別では、疼痛緩和分野が2022年のオピオイド市場を席巻し、慢性疼痛患者の増加により大幅な市場成長が見込まれます。カナダ健康情報研究所とカナダ疼痛タスクフォースの2021年報告書によると、カナダでは成人の5人に1人が慢性疼痛に苦しんでいます。

- 投与経路別では、注射剤が2022年のオピオイド市場を席巻しました。この優位性は、慢性疼痛の治療に使用される製品が広く入手可能であること、麻酔を必要とする処置が増加していることに起因します。

- 流通チャネル別では、小売薬局が2022年のオピオイド市場を席巻しました。オピオイドの調剤率が高い小売薬局が存在することが、同分野の成長を牽引しています。

- 予測期間中、アジア太平洋地域が最も急成長する見込みです。同地域の成長は、慢性疼痛に罹患しやすい老年人口の増加に起因しています。

第1章. 調査方法・範囲
第2章. エグゼクティブサマリー
第3章. 市場変動・動向・範囲
第4章. 世界のオピオイド市場：製品別予測・動向分析
第5章. 世界のオピオイド市場：用途別予測・動向分析
第6章. 世界のオピオイド市場：投与経路別予測・動向分析
第7章. 世界のオピオイド市場：流通チャネル別予測・動向分析
第8章. 世界のオピオイド市場：地域別予測・動向分析
第9章. 競争状況

グローバル市場調査レポート販売サイトのwww.marketreport.jpです。

❖ レポートの目次 ❖

Table of Contents

Chapter 1. Methodology and Scope
1.1. Market Segmentation & Scope
1.1.1. Product
1.1.2. Application
1.1.3. Route of administration
1.1.4. Distribution channel
1.1.5. Regional scope
1.1.6. Estimates and forecast timeline
1.2. Research Methodology
1.3. Information Procurement
1.3.1. Purchased database
1.3.2. GVR’s internal database
1.3.3. Secondary sources
1.3.4. Primary research
1.3.5. Details of primary research
1.4. Information or Data Analysis
1.5. Market Formulation & Validation
1.6. Model Details
1.7. List of Secondary Sources
1.8. List of Primary Sources
1.9. Objectives
Chapter 2. Executive Summary
2.1. Market Outlook
2.2. Segment Outlook
2.2.1. Product outlook
2.2.2. Application outlook
2.2.3. Route of administration outlook
2.2.4. Distribution channel outlook
2.2.5. Regional outlook
2.3. Competitive Insights
Chapter 3. Opioids Market Variables, Trends & Scope
3.1. Market Lineage Outlook
3.1.1. Parent market outlook
3.1.2. Related/ancillary market outlook
3.2. Penetration & Growth Prospect Mapping
3.3. Market Dynamics
3.3.1. Market driver analysis
3.3.2. Market restraint analysis
3.4. Opioids Market Analysis Tools
3.4.1. Industry Analysis – Porter’s
3.4.1.1. Supplier power
3.4.1.2. Buyer power
3.4.1.3. Substitution threat
3.4.1.4. Threat of new entrant
3.4.1.5. Competitive rivalry
3.4.2. PESTEL Analysis
3.4.2.1. Political landscape
3.4.2.2. Technological landscape
3.4.2.3. Economic landscape
Chapter 4. Opioids: Product Estimates & Trend Analysis
4.1. Opioids Market: Key Takeaways
4.2. Opioids Market: Movement & Market Share Analysis, 2022 & 2030
4.3. IR/Short Acting Opioids
4.3.1. IR/ Short Acting Opioids market estimates and forecasts, 2018 to 2030 (USD Million)
4.4. ER/Long Acting Opioids
4.4.1. ER/ Long Acting Opioids market estimates and forecasts, 2018 to 2030 (USD Million)
Chapter 5. Opioids: Application Estimates & Trend Analysis
5.1. Opioids Market: Key Takeaways
5.2. Opioids Market: Movement & Market Share Analysis, 2022 & 2030
5.3. Pain Relief
5.3.1. Pain relief market estimates and forecasts, 2018 to 2030 (USD Million)
5.4. Anesthesia
5.4.1. Anesthesia market estimates and forecasts, 2018 to 2030 (USD Million)
5.5. Cough Suppression
5.5.1. Cough suppression market estimates and forecasts, 2018 to 2030 (USD Million)
5.6. Diarrhea Suppression
5.6.1. Diarrhea suppression market estimates and forecasts, 2018 to 2030 (USD Million)
5.7. De-addiction
5.7.1. De-addiction market estimates and forecasts, 2018 to 2030 (USD Million)
Chapter 6. Opioids: Route of Administration Estimates & Trend Analysis
6.1. Opioids Market: Key Takeaways
6.2. Opioids Market: Movement & Market Share Analysis, 2022 & 2030
6.3. Oral
6.3.1. Oral market estimates and forecasts, 2018 to 2030 (USD Million)
6.4. Injectable
6.4.1. Injectable market estimates and forecasts, 2018 to 2030 (USD Million)
6.5. Others
6.5.1. Others market estimates and forecasts, 2018 to 2030 (USD Million)
Chapter 7. Opioids: Distribution Channel Estimates & Trend Analysis
7.1. Opioids Market: Key Takeaways
7.2. Opioids Market: Movement & Market Share Analysis, 2022 & 2030
7.3. Hospital Pharmacy
7.3.1. Hospital pharmacy market estimates and forecasts, 2018 to 2030 (USD Million)
7.4. Retail Pharmacy
7.4.1. Retail Pharmacy market estimates and forecasts, 2018 to 2030 (USD Million)
7.5. Others
7.5.1. Others market estimates and forecasts, 2018 to 2030 (USD Million)
Chapter 8. Opioids Market: Regional Estimates & Trend Analysis
8.1. Regional Outlook
8.2. Opioids Market by Region: Key Takeaways
8.3. North America
8.3.1. Market estimates and forecasts, 2018 – 2030 (Revenue, USD Million)
8.3.2. U.S.
8.3.2.1. Market estimates and forecasts, 2018 – 2030 (Revenue, USD Million)
8.3.3. Canada
8.3.3.1. Market estimates and forecasts, 2018 – 2030 (Revenue, USD Million)
8.4. Europe
8.4.1. UK
8.4.1.1. Market estimates and forecasts, 2018 – 2030 (Revenue, USD Million)
8.4.2. Germany
8.4.2.1. Market estimates and forecasts, 2018 – 2030 (Revenue, USD Million)
8.4.3. France
8.4.3.1. Market estimates and forecasts, 2018 – 2030 (Revenue, USD Million)
8.4.4. Italy
8.4.4.1. Market estimates and forecasts, 2018 – 2030 (Revenue, USD Million)
8.4.5. Spain
8.4.5.1. Market estimates and forecasts, 2018 – 2030 (Revenue, USD Million)
8.4.6. Sweden
8.4.6.1. Market estimates and forecasts, 2018 – 2030 (Revenue, USD Million)
8.4.7. Norway
8.4.7.1. Market estimates and forecasts, 2018 – 2030 (Revenue, USD Million)
8.4.8. Denmark
8.4.8.1. Market estimates and forecasts, 2018 – 2030 (Revenue, USD Million)
8.5. Asia Pacific
8.5.1. Japan
8.5.1.1. Market estimates and forecasts, 2018 – 2030 (Revenue, USD Million)
8.5.2. China
8.5.2.1. Market estimates and forecasts, 2018 – 2030 (Revenue, USD Million)
8.5.3. India
8.5.3.1. Market estimates and forecasts, 2018 – 2030 (Revenue, USD Million)
8.5.4. Australia
8.5.4.1. Market estimates and forecasts, 2018 – 2030 (Revenue, USD Million)
8.5.5. Thailand
8.5.5.1. Market estimates and forecasts, 2018 – 2030 (Revenue, USD Million)
8.5.6. South Korea
8.5.6.1. Market estimates and forecasts, 2018 – 2030 (Revenue, USD Million)
8.6. Latin America
8.6.1. Brazil
8.6.1.1. Market estimates and forecasts, 2018 – 2030 (Revenue, USD Million)
8.6.2. Mexico
8.6.2.1. Market estimates and forecasts, 2018 – 2030 (Revenue, USD Million)
8.6.3. Argentina
8.6.3.1. Market estimates and forecasts, 2018 – 2030 (Revenue, USD Million)
8.7. MEA
8.7.1. Saudi Arabia
8.7.1.1. Market estimates and forecasts, 2018 – 2030 (Revenue, USD Million)
8.7.2. South Africa
8.7.2.1. Market estimates and forecasts, 2018 – 2030 (Revenue, USD Million)
8.7.3. UAE
8.7.3.1. Market estimates and forecasts, 2018 – 2030 (Revenue, USD Million)
8.7.4. Kuwait
8.7.4.1. Market estimates and forecasts, 2018 – 2030 (Revenue, USD Million)
Chapter 9. Competitive Landscape
9.1. Recent Developments & Impact Analysis, By Key Market Participants
9.2. Market Participant Categorization
9.2.1. Purdue Pharma L.P.
9.2.1.1. Company overview
9.2.1.2. Financial performance
9.2.1.3. Product benchmarking
9.2.1.4. Strategic initiatives
9.2.2. Johnson & Johnson Services, Inc.
9.2.2.1. Company overview
9.2.2.2. Financial performance
9.2.2.3. Product benchmarking
9.2.2.4. Strategic initiatives
9.2.3. Hikma Pharmaceuticals PLC
9.2.3.1. Company overview
9.2.3.2. Financial performance
9.2.3.3. Product benchmarking
9.2.3.4. Strategic initiatives
9.2.4. Pfizer Inc.
9.2.4.1. Company overview
9.2.4.2. Financial performance
9.2.4.3. Product benchmarking
9.2.4.4. Strategic initiatives
9.2.5. AbbVie Inc.
9.2.5.1. Company overview
9.2.5.2. Financial performance
9.2.5.3. Product benchmarking
9.2.5.4. Strategic initiatives
9.2.6. Sanofi
9.2.6.1. Company overview
9.2.6.2. Financial performance
9.2.6.3. Product benchmarking
9.2.6.4. Strategic initiatives
9.2.7. Sun Pharmaceutical Industries Ltd
9.2.7.1. Company overview
9.2.7.2. Financial performance
9.2.7.3. Product benchmarking
9.2.7.4. Strategic initiatives
9.2.8. Grünenthal
9.2.8.1. Company overview
9.2.8.2. Financial performance
9.2.8.3. Product benchmarking
9.2.8.4. Strategic initiatives
9.2.9. Merck & Co., Inc.
9.2.9.1. Company overview
9.2.9.2. Financial performance
9.2.9.3. Product benchmarking
9.2.9.4. Strategic initiatives

List of Tables

Table 1 List of Abbreviation
Table 2 North America opioids market, by product, 2018 - 2030 (USD Million)
Table 3 North America opioids market, by application, 2018 - 2030 (USD Million)
Table 4 North America opioids market, by route of administration, (USD Million) 2018 - 2030
Table 5 North America opioids market, by distribution channel, 2018 - 2030 (USD Million)
Table 6 North America opioids market, by region, 2018 - 2030 (USD Million)
Table 7 U.S. opioids market, by product, 2018 - 2030 (USD Million)
Table 8 U.S. opioids market, by application, 2018 - 2030 (USD Million)
Table 9 U.S. opioids market, by route of administration, (USD Million) 2018 - 2030
Table 10 U.S. opioids market, by distribution channel, 2018 - 2030 (USD Million)
Table 11 Canada opioids market, by product, 2018 - 2030 (USD Million)
Table 12 Canada opioids market, by application, 2018 - 2030 (USD Million)
Table 13 Canada opioids market, by route of administration, (USD Million) 2018 - 2030
Table 14 Canada opioids market, by distribution channel, 2018 - 2030 (USD Million)
Table 15 Europe opioids market, by product, 2018 - 2030 (USD Million)
Table 16 Europe opioids market, by application, 2018 - 2030 (USD Million)
Table 17 Europe opioids market, by route of administration, (USD Million) 2018 - 2030
Table 18 Europe opioids market, by distribution channel, 2018 - 2030 (USD Million)
Table 19 Europe opioids market, by region, 2018 - 2030 (USD Million)
Table 20 Germany opioids market, by product, 2018 - 2030 (USD Million)
Table 21 Germany opioids market, by application, 2018 - 2030 (USD Million)
Table 22 Germany opioids market, by route of administration, (USD Million) 2018 - 2030
Table 23 Germany opioids market, by distribution channel, 2018 - 2030 (USD Million)
Table 24 UK opioids market, by product, 2018 - 2030 (USD Million)
Table 25 UK opioids market, by application, 2018 - 2030 (USD Million)
Table 26 UK opioids market, by route of administration, (USD Million) 2018 - 2030
Table 27 UK opioids market, by distribution channel, 2018 - 2030 (USD Million)
Table 28 France opioids market, by product, 2018 - 2030 (USD Million)
Table 29 France opioids market, by application, 2018 - 2030 (USD Million)
Table 30 France opioids market, by route of administration, (USD Million) 2018 - 2030
Table 31 France opioids market, by distribution channel, 2018 - 2030 (USD Million)
Table 32 Italy opioids market, by product, 2018 - 2030 (USD Million)
Table 33 Italy opioids market, by application, 2018 - 2030 (USD Million)
Table 34 Italy opioids market, by route of administration, (USD Million) 2018 - 2030
Table 35 Italy opioids market, by distribution channel, 2018 - 2030 (USD Million)
Table 36 Spain opioids market, by product, 2018 - 2030 (USD Million)
Table 37 Spain opioids market, by application, 2018 - 2030 (USD Million)
Table 38 Spain opioids market, by route of administration, (USD Million) 2018 - 2030
Table 39 Spain opioids market, by distribution channel, 2018 - 2030 (USD Million)
Table 40 Denmark opioids market, by product, 2018 - 2030 (USD Million)
Table 41 Denmark opioids market, by application, 2018 - 2030 (USD Million)
Table 42 Denmark opioids market, by route of administration, (USD Million) 2018 - 2030
Table 43 Denmark opioids market, by distribution channel, 2018 - 2030 (USD Million)
Table 44 Sweden opioids market, by product, 2018 - 2030 (USD Million)
Table 45 Sweden opioids market, by application, 2018 - 2030 (USD Million)
Table 46 Sweden opioids market, by route of administration, (USD Million) 2018 - 2030
Table 47 Sweden opioids market, by distribution channel, 2018 - 2030 (USD Million)
Table 48 Norway opioids market, by product, 2018 - 2030 (USD Million)
Table 49 Norway opioids market, by application, 2018 - 2030 (USD Million)
Table 50 Norway opioids market, by route of administration, (USD Million) 2018 - 2030
Table 51 Norway opioids market, by distribution channel, 2018 - 2030 (USD Million)
Table 52 Asia Pacific opioids market, by product, 2018 - 2030 (USD Million)
Table 53 Asia Pacific opioids market, by application, 2018 - 2030 (USD Million)
Table 54 Asia Pacific opioids market, by route of administration, (USD Million) 2018 - 2030
Table 55 Asia Pacific opioids market, by distribution channel, 2018 - 2030 (USD Million)
Table 56 Asia Pacific opioids market, by region, 2018 - 2030 (USD Million)
Table 57 Japan opioids market, by product, 2018 - 2030 (USD Million)
Table 58 Japan opioids market, by application, 2018 - 2030 (USD Million)
Table 59 Japan opioids market, by route of administration, (USD Million) 2018 - 2030
Table 60 Japan opioids market, by distribution channel, 2018 - 2030 (USD Million)
Table 61 China opioids market, by product, 2018 - 2030 (USD Million)
Table 62 China opioids market, by application, 2018 - 2030 (USD Million)
Table 63 China opioids market, by route of administration, (USD Million) 2018 - 2030
Table 64 China opioids market, by distribution channel, 2018 - 2030 (USD Million)
Table 65 India opioids market, by product, 2018 - 2030 (USD Million)
Table 66 India opioids market, by application, 2018 - 2030 (USD Million)
Table 67 India opioids market, by route of administration, (USD Million) 2018 - 2030
Table 68 India opioids market, by distribution channel, (USD Million) 2018 - 2030
Table 69 Australia opioids market, by product, 2018 - 2030 (USD Million)
Table 70 Australia opioids market, by application, 2018 - 2030 (USD Million)
Table 71 Australia opioids market, by route of administration, (USD Million) 2018 - 2030
Table 72 Australia opioids market, by distribution channel, 2018 - 2030 (USD Million)
Table 73 Thailand opioids market, by product, 2018 - 2030 (USD Million)
Table 74 Thailand opioids market, by application, 2018 - 2030 (USD Million)
Table 75 Thailand opioids market, by route of administration, (USD Million) 2018 - 2030
Table 76 Thailand opioids market, by distribution channel, 2018 - 2030 (USD Million)
Table 77 South Korea opioids market, by product, 2018 - 2030 (USD Million)
Table 78 South Korea opioids market, by application, 2018 - 2030 (USD Million)
Table 79 South Korea opioids market, by route of administration, 2018 - 2030 (USD Million)
Table 80 South Korea opioids market, by distribution channel, 2018 - 2030 (USD Million)
Table 81 Latin America opioids market, by product, 2018 - 2030 (USD Million)
Table 82 Latin America opioids market, by application, 2018 - 2030 (USD Million)
Table 83 Latin America opioids market, by route of administration, (USD Million) 2018 - 2030
Table 84 Latin America opioids market, by distribution channel, 2018 - 2030 (USD Million)
Table 85 Latin America opioids market, by region, 2018 - 2030 (USD Million)
Table 86 Brazil opioids market, by product, 2018 - 2030 (USD Million)
Table 87 Brazil opioids market, by application, 2018 - 2030 (USD Million)
Table 88 Brazil opioids market, by route of administration, 2018 - 2030 (USD Million)
Table 89 Brazil opioids market, by distribution channel, 2018 - 2030 (USD Million)
Table 90 Mexico opioids market, by product, 2018 - 2030 (USD Million)
Table 91 Mexico opioids market, by application, 2018 - 2030 (USD Million)
Table 92 Mexico opioids market, by route of administration, (USD Million) 2018 - 2030
Table 93 Mexico opioids market, by distribution channel, 2018 - 2030 (USD Million)
Table 94 Argentina opioids market, by product, 2018 - 2030 (USD Million)
Table 95 Argentina opioids market, by application, 2018 - 2030 (USD Million)
Table 96 Argentina opioids market, by route of administration, (USD Million) 2018 - 2030
Table 97 Argentina opioids market, by distribution channel, 2018 - 2030 (USD Million)
Table 98 Middle East and Africa opioids market, by product, 2018 - 2030 (USD Million)
Table 99 Middle East and Africa opioids market, by application, 2018 - 2030 (USD Million)
Table 100 Middle East and Africa opioids market, by route of administration, (USD Million) 2018 - 2030
Table 101 Middle East and Africa opioids market, by distribution channel, 2018 - 2030 (USD Million)
Table 102 Middle East and Africa opioids market, by region, 2018 - 2030 (USD Million)
Table 103 South Africa opioids market, by product, 2018 - 2030 (USD Million)
Table 104 South Africa opioids market, by application, 2018 - 2030 (USD Million)
Table 105 South Africa opioids market, by route of administration, (USD Million) 2018 - 2030
Table 106 South Africa opioids market, by distribution channel, 2018 - 2030 (USD Million)
Table 107 Saudi Arabia opioids market, by product, 2018 - 2030 (USD Million)
Table 108 Saudi Arabia opioids market, by application, 2018 - 2030 (USD Million)
Table 109 Saudi Arabia opioids market, by route of administration, (USD Million) 2018 - 2030
Table 110 Saudi Arabia opioids market, by distribution channel, 2018 - 2030 (USD Million)
Table 111 UAE opioids market, by product, 2018 - 2030 (USD Million)
Table 112 UAE opioids market, by application, 2018 - 2030 (USD Million)
Table 113 UAE opioids market, by route of administration, (USD Million) 2018 - 2030
Table 114 UAE opioids market, by distribution channel, 2018 - 2030 (USD Million)
Table 115 Kuwait opioids market, by product, 2018 - 2030 (USD Million)
Table 116 Kuwait opioids market, by application, 2018 - 2030 (USD Million)
Table 117 Kuwait opioids market, by route of administration, 2018 - 2030 (USD Million)
Table 118 Kuwait opioids market, by distribution channel, 2018 - 2030 (USD Million)

List of Figures

Fig. 1 Market research process
Fig. 2 Data triangulation techniques
Fig. 3 Primary research pattern
Fig. 4 Market research approaches
Fig. 5 Value-chain-based sizing & forecasting
Fig. 6 QFD modeling for market share assessment
Fig. 7 Market formulation & validation
Fig. 8 Opioids: Market outlook
Fig. 9 Opioids: Competitive insights
Fig. 10 Parent market outlook
Fig. 11 Related/ancillary market outlook
Fig. 12 Penetration and growth prospect mapping
Fig. 13 Industry value chain analysis
Fig. 14 Opioids market driver impact
Fig. 15 Opioids market restraint impact
Fig. 16 Opioids market strategic initiatives analysis
Fig. 17 Opioids market: Product movement analysis
Fig. 18 Opioids market: Product outlook and key takeaways
Fig. 19 IR/Short acting opioids market estimates and forecasts, 2018 - 2030
Fig. 20 ER/Long acting opioids market estimates and forecasts, 2018 - 2030
Fig. 21 Opioids market: Application movement analysis
Fig. 22 Opioids market: Application outlook and key takeaways
Fig. 23 Pain relief market estimates and forecasts, 2018 - 2030
Fig. 24 Anesthesia market estimates and forecasts, 2018 - 2030
Fig. 25 Cough suppression market estimates and forecasts, 2018 - 2030
Fig. 26 Diarrhea suppression market estimates and forecasts, 2018 – 2030
Fig. 27 De-addiction market estimates and forecasts, 2018 - 2030
Fig. 28 Opioids market: Route of administration movement analysis
Fig. 29 Opioids market: Route of administration outlook and key takeaways
Fig. 30 Oral market estimates and forecasts, 2018 - 2030
Fig. 31 Injectable market estimates and forecasts, 2018 - 2030
Fig. 32 Others market estimates and forecasts, 2018 – 2030
Fig. 33 Opioids market: Distribution channel movement analysis
Fig. 34 Opioids market: Distribution channel outlook and key takeaways
Fig. 35 Hospital pharmacy market estimates and forecasts, 2018 - 2030
Fig. 36 Retail pharmacy market estimates and forecasts, 2018 – 2030
Fig. 37 Others market estimates and forecasts, 2018 - 2030
Fig. 38 Global opioids market: Regional movement analysis
Fig. 39 Global opioids market: Regional outlook and key takeaways
Fig. 40 North America market estimates and forecasts, 2018 - 2030
Fig. 41 U.S. market estimates and forecasts, 2018 - 2030
Fig. 42 Canada market estimates and forecasts, 2018 - 2030
Fig. 43 Europe market estimates and forecasts, 2018 - 2030
Fig. 44 UK market estimates and forecasts, 2018 - 2030
Fig. 45 Germany market estimates and forecasts, 2018 - 2030
Fig. 46 France market estimates and forecasts, 2018 - 2030
Fig. 47 Italy market estimates and forecasts, 2018 - 2030
Fig. 48 Spain market estimates and forecasts, 2018 - 2030
Fig. 49 Denmark market estimates and forecasts, 2018 - 2030
Fig. 50 Sweden market estimates and forecasts, 2018 - 2030
Fig. 51 Norway market estimates and forecasts, 2018 - 2030
Fig. 52 Asia Pacific market estimates and forecasts, 2018 - 2030
Fig. 53 Japan market estimates and forecasts, 2018 - 2030
Fig. 54 China market estimates and forecasts, 2018 - 2030
Fig. 55 India market estimates and forecasts, 2018 - 2030
Fig. 56 Australia market estimates and forecasts, 2018 - 2030
Fig. 57 Thailand market estimates and forecasts, 2018 - 2030
Fig. 58 South Korea market estimates and forecasts, 2018 - 2030
Fig. 59 Latin America market estimates and forecasts, 2018 - 2030
Fig. 60 Brazil market estimates and forecasts, 2018 - 2030
Fig. 61 Mexico market estimates and forecasts, 2018 - 2030
Fig. 62 Argentina market estimates and forecasts, 2018 - 2030
Fig. 63 Middle East and Africa. market estimates and forecasts, 2018 - 2030
Fig. 64 South Africa market estimates and forecasts, 2018 - 2030
Fig. 65 Saudi Arabia market estimates and forecasts, 2018 - 2030
Fig. 66 UAE market estimates and forecasts, 2018 - 2030
Fig. 67 Kuwait market estimates and forecasts, 2018 - 2030

★調査レポート[世界のオピオイド市場（2023-2030）：製品別（IR/短時間作用型オピオイド、ER/長時間作用型オピオイド）、用途別（疼痛緩和、麻酔）、投与経路別、流通チャネル別、地域別] (コード：GRV23NOV277)販売に関する免責事項を必ずご確認ください。
★調査レポート[世界のオピオイド市場（2023-2030）：製品別（IR/短時間作用型オピオイド、ER/長時間作用型オピオイド）、用途別（疼痛緩和、麻酔）、投与経路別、流通チャネル別、地域別]についてメールでお問い合わせ
◆関連市場調査レポート◆
  • 世界のワクチンデリバリーデバイス市場（2023-2030）：デバイス別、投与経路別（皮内接種、筋肉内接種、皮下接種）、地域別
  • 世界の反芻動物用ワクチン市場（2023-2030）：動物種類別（ウシ、ヒツジ、ヤギ）、ワクチン種類別（改良型／弱毒生ワクチン）、効能別、投与経路別、地域別
  • 世界の抗感染症薬市場2023-2030：種類/薬剤クラス別（抗ウイルス薬、抗真菌薬）、投与経路別、流通チャネル別、地域別
  • 世界の降圧薬市場2024-2030：薬剤クラス別（利尿薬、ACE阻害薬）、種類別（一次、二次）、投与経路別、流通チャネル別、地域別
  • 世界のインフルエンザ治療薬市場2024-2030：治療薬別（ペラミビル、ザナミビル、バロキサビル マルボキシル、リン酸オセルタミビル）、投与経路別、流通チャネル別、地域別
  • 世界の肉腫治療薬市場（2023-2030）：治療種類別（化学療法、標的療法）、流通チャネル別（病院薬局、小売薬局、オンライン薬局）、地域別

    • ◆H&Iグローバルリサーチのお客様（例）◆